Literature DB >> 14648606

Determination of paeonol in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies following oral administration of Moutan cortex decoction.

Xinan Wu1, Hongli Chen, Xingguo Chen, Zhide Hu.   

Abstract

Quantification of paeonol, the principal bioactive component of Moutan cortex, in rat plasma following oral administration of Moutan cortex decoction was achieved by using a simple and sensitive high-performance liquid chromatographic method. The calibration curves for paeonol were linear in both the low (25-200 ng/mL) and the high concentration range (200-4000 ng/mL) with r(2) values of 0.9928 and 0.9993, respectively. The coefficients of variation of intra- and inter-day assays were 14.36, 6.52, 1.76, 1.25, 5.36, 3.30 and 1.42% and 12.70, 1.19, 2.98, 1.91, 1.75, 1.78 and 0.96% at concentrations of 25, 50, 100, 200, 500, 1000 and 2000 ng/mL, respectively. The recoveries of paeonol from rat plasma were found to be 101.9, 104.5, 105.4 and 101.2% for concentrations of 50, 500, 1000 and 2000 ng/mL, respectively. The paeonol plasma concentrations were fitted to two-compartment model with fi rst order absorption. The mean terminal half-lives (t(1/2)) of paeonol was 80.9 min. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648606     DOI: 10.1002/bmc.259

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  8 in total

1.  Action potential bursts in central snail neurons elicited by paeonol: roles of ionic currents.

Authors:  Yi-hung CHEN; Pei-lin LIN; Hui-yu HSU; Ya-ting WU; Han-yin YANG; Dah-yuu LU; Shiang-suo HUANG; Ching-liang HSIEH; Jaung-geng LIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

2.  Pharmacokinetics of the main compounds absorbed into blood after oral administration of Liu Wei Di Huang Wan, a typical combinatorial intervention of Chinese medical formula.

Authors:  Ning Zhang; Lijing Li; Ping Wang; Hui Sun; Zeming Wu; Chengyu Piao; Xijun Wang
Journal:  J Nat Med       Date:  2012-02-26       Impact factor: 2.343

3.  Paeonol pharmacokinetics in the rat following i.m. administration.

Authors:  Li-Yan Ma; Xu-Dong Xu; Qi Zhang; Jian-Hua Miao; Bing-Lan Tang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

4.  Transdermal delivery of paeonol using cubic gel and microemulsion gel.

Authors:  Maofu Luo; Qi Shen; Jinjin Chen
Journal:  Int J Nanomedicine       Date:  2011-08-04

Review 5.  Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis.

Authors:  Li Lu; Yating Qin; Chen Chen; Xiaomei Guo
Journal:  Oxid Med Cell Longev       Date:  2018-11-07       Impact factor: 6.543

6.  Paeonol, an Ingredient of Kamishoyosan, Reduces Intracellular Lipid Accumulation by Inhibiting Glucocorticoid Receptor Activity in 3T3-L1 Cells.

Authors:  Masayuki Izumi; Takashi Yoshida; Takashi Nakamura; And Minoru Wakamori
Journal:  Nutrients       Date:  2020-01-24       Impact factor: 5.717

7.  Integrating pharmacokinetics and network analysis to investigate the mechanism of Moutan Cortex in blood-heat and blood stasis syndrome.

Authors:  Qiuli Ye; Ying Zhang; Donghui Yan; Yue Sun; Ming Li; Hui Cao; Shumei Wang; Jiang Meng
Journal:  Chin Med       Date:  2022-09-14       Impact factor: 4.546

8.  Role of Paeonol in an Astrocyte Model of Parkinson's Disease.

Authors:  Maosheng Ye; Yuxin Yi; Shixing Wu; Yong Zhou; Dongjie Zhao
Journal:  Med Sci Monit       Date:  2017-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.